SA detects first case of Lassa fever in 15 years
The National Institute of Communicable Diseases has reported the detection of an imported case of Lassa fever in South Africa, the first since 2007.
In a statement released on Friday night, the NICD said a man with an extensive history of travel in Nigeria fell sick soon after returning to South Africa. He was admitted to Pietermaritzburg Hospital where he died.
Lassa fever is a viral infection that is endemic to the West African countries and mostly reported in Sierra Leone, Liberia, Guinea, and Nigeria. Up to 300 000 cases of Lassa fever, with about 5000 deaths, are recorded annually in the endemic countries. Currently, there is no vaccine for Lassa fever.
Lassa fever Kills 149 in Four Months, Says NCDC https://t.co/mXYiFMMsqQ
— Medicalworld Nigeria (@MedicalworldNig) May 13, 2022
A species of rodent called the multimammate rat is the natural host of the virus that causes Lassa fever. The rats are persistently infected and shed the virus in their urine and faeces. Humans can come into contact with the virus through direct contact or inhalation of the virus in areas that are infested with the infected rats.
Track and tracing of contacts underway
“The man had extensive travel history in Nigeria before returning to South Africa. The diagnosis of Lassa fever was confirmed through laboratory testing,” the statement read.
Efforts are currently underway to trace and monitor anyone who had contact with the man. However, no secondary cases of Lassa fever have been confirmed as yet.
Person-to-person transmission of the virus does not occur readily and the virus is not spread through casual contact. Person-to-person transmission is mostly associated with the hospital setting where healthcare workers have contact with the infected blood and bodily fluids of a patient.
Cases of Lassa fever in travellers returning from endemic countries are reported from time to time. The last case of Lassa fever in SA was reported in 2007 when a Nigerian citizen fell ill. The person also had extensive travel history in rural parts of Nigeria before falling ill. – Health-e News
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
SA detects first case of Lassa fever in 15 years
by healthe, Health-e News
May 13, 2022
One comment
0.5